Antihypertensive treatment in reducing the risk of dementia [3]

Stroke

Volumn 37, Issue 12, 2006, Pages 2869-

  Hadjiev, Dimiter ^a   Mineva, Petya ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BRAIN BLOOD VESSEL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DRUG USE; EVALUATION; FOLLOW UP; HUMAN; HYPERTENSION; LETTER; LONG TERM CARE; NEUROPSYCHOLOGICAL TEST; PERFORMANCE; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANTIHYPERTENSIVE AGENTS; DEMENTIA; HUMANS; HYPERTENSION; MALE; RISK FACTORS;

EID: 33845465493     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000248245.57361.42     Document Type: Letter

References (5)

1. Peila R, White LR, Masaki K, Petrovitch H, Launer LJ. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke. 2006;37:1165-1170.
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
3. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347-1351.
4. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci. 2005;229-230:151-155.
5. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rew. 2006;(2):CD004034.